Loading…
Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review
The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibil...
Saved in:
Published in: | Pharmaceutics 2023-04, Vol.15 (4), p.1306 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53 |
container_end_page | |
container_issue | 4 |
container_start_page | 1306 |
container_title | Pharmaceutics |
container_volume | 15 |
creator | Jîtcă, Carmen-Maria Jîtcă, George Ősz, Bianca-Eugenia Pușcaș, Amalia Imre, Silvia |
description | The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibility and acceptability, the compounding practices are not endorsed by the health authorities, and achieving stability can be problematic. The purpose of this study is to provide a comprehensive overview of the stability of liquid oral dosage forms used in pediatric cardiology. An extensive review of the literature has been performed, with a particular focus on cardiovascular pharmacotherapy, by consulting the current studies indexed in PubMed, ScienceDirect, PLoS One, and Google Scholar databases. Regulations and guidelines have been considered against the studies found in the literature. Overall, the stability study is well-designed, and the critical quality attributes (CQAs) have been selected for testing. Several approaches have been identified as innovative in order to optimize stability, but opportunities to improve have been also identified, such as in-use studies and achieving dose standardization. Consequently, the information gathering and the results of the studies can be translated into clinical practice in order to achieve the desired stability of liquid oral dosage forms. |
doi_str_mv | 10.3390/pharmaceutics15041306 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6044b29f03f34a55993f65b59d7bcf8c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A747471679</galeid><doaj_id>oai_doaj_org_article_6044b29f03f34a55993f65b59d7bcf8c</doaj_id><sourcerecordid>A747471679</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53</originalsourceid><addsrcrecordid>eNptUl1v0zAUjRCITWM_AWSJB3jpsOM4iXlBVWEwqWIVg2frJrnuXCVxZydF_fe7XUe1ovk82Lo-51zdjyR5K_iFlJp_Wt9C6KDGcXB1FIpnQvL8RXIqtNaTTKfy5ZP3SXIe44rTkVKUUr9OTmQhhCi0OE3GmwEq17phy7xl1wFaNnd3o2vYVx9hiezShy4y17MFNg6G4Go2g9A43_rl9jObskXAgKSIbkBmfWALGBz2w4fIbsDisJ1M2U8IgaIbZL9w4_Dvm-SVhTbi-eN9lvy5_PZ79mMyv_5-NZvOJ7VKxTCREhqQmbaaV6lGrsGWBCjTlJe2yq0WokxzLJRKdakrq5sUBKYlgCYoeZZc7X0bDyuzDq6DsDUenHkI-LA0EKiHLZqcZxklsVxamYFSWkubq0rppqhqW9bk9WXvtR6rDpuaSqRuHZke__Tu1iz9xgguspTsyeHjo0PwdyPGwXQu1ti20KMfo0lLTjPROc-J-v4_6sqPoade7Vi5KrimmR9YS6AKXG89Ja53pmZaZASRF5pYF8-wCA12rvY9WkfxI4HaC-rgYwxoD0UKbnb7Z57dP9K9e9qhg-rftsl7HozY8Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2806570941</pqid></control><display><type>article</type><title>Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Jîtcă, Carmen-Maria ; Jîtcă, George ; Ősz, Bianca-Eugenia ; Pușcaș, Amalia ; Imre, Silvia</creator><creatorcontrib>Jîtcă, Carmen-Maria ; Jîtcă, George ; Ősz, Bianca-Eugenia ; Pușcaș, Amalia ; Imre, Silvia</creatorcontrib><description>The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibility and acceptability, the compounding practices are not endorsed by the health authorities, and achieving stability can be problematic. The purpose of this study is to provide a comprehensive overview of the stability of liquid oral dosage forms used in pediatric cardiology. An extensive review of the literature has been performed, with a particular focus on cardiovascular pharmacotherapy, by consulting the current studies indexed in PubMed, ScienceDirect, PLoS One, and Google Scholar databases. Regulations and guidelines have been considered against the studies found in the literature. Overall, the stability study is well-designed, and the critical quality attributes (CQAs) have been selected for testing. Several approaches have been identified as innovative in order to optimize stability, but opportunities to improve have been also identified, such as in-use studies and achieving dose standardization. Consequently, the information gathering and the results of the studies can be translated into clinical practice in order to achieve the desired stability of liquid oral dosage forms.</description><identifier>ISSN: 1999-4923</identifier><identifier>EISSN: 1999-4923</identifier><identifier>DOI: 10.3390/pharmaceutics15041306</identifier><identifier>PMID: 37111791</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age ; Cardiology ; Dosage and administration ; dosage form ; Drug dosages ; Drug stability ; Evaluation ; FDA approval ; Federal regulation ; Good Manufacturing Practice ; oral liquid ; Oral medication ; pediatric ; Pediatric cardiology ; Pediatrics ; Pharmaceutical industry ; Review ; Safety and security measures ; stability</subject><ispartof>Pharmaceutics, 2023-04, Vol.15 (4), p.1306</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53</cites><orcidid>0000-0001-8187-126X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2806570941/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2806570941?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37111791$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jîtcă, Carmen-Maria</creatorcontrib><creatorcontrib>Jîtcă, George</creatorcontrib><creatorcontrib>Ősz, Bianca-Eugenia</creatorcontrib><creatorcontrib>Pușcaș, Amalia</creatorcontrib><creatorcontrib>Imre, Silvia</creatorcontrib><title>Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review</title><title>Pharmaceutics</title><addtitle>Pharmaceutics</addtitle><description>The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibility and acceptability, the compounding practices are not endorsed by the health authorities, and achieving stability can be problematic. The purpose of this study is to provide a comprehensive overview of the stability of liquid oral dosage forms used in pediatric cardiology. An extensive review of the literature has been performed, with a particular focus on cardiovascular pharmacotherapy, by consulting the current studies indexed in PubMed, ScienceDirect, PLoS One, and Google Scholar databases. Regulations and guidelines have been considered against the studies found in the literature. Overall, the stability study is well-designed, and the critical quality attributes (CQAs) have been selected for testing. Several approaches have been identified as innovative in order to optimize stability, but opportunities to improve have been also identified, such as in-use studies and achieving dose standardization. Consequently, the information gathering and the results of the studies can be translated into clinical practice in order to achieve the desired stability of liquid oral dosage forms.</description><subject>Age</subject><subject>Cardiology</subject><subject>Dosage and administration</subject><subject>dosage form</subject><subject>Drug dosages</subject><subject>Drug stability</subject><subject>Evaluation</subject><subject>FDA approval</subject><subject>Federal regulation</subject><subject>Good Manufacturing Practice</subject><subject>oral liquid</subject><subject>Oral medication</subject><subject>pediatric</subject><subject>Pediatric cardiology</subject><subject>Pediatrics</subject><subject>Pharmaceutical industry</subject><subject>Review</subject><subject>Safety and security measures</subject><subject>stability</subject><issn>1999-4923</issn><issn>1999-4923</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUl1v0zAUjRCITWM_AWSJB3jpsOM4iXlBVWEwqWIVg2frJrnuXCVxZydF_fe7XUe1ovk82Lo-51zdjyR5K_iFlJp_Wt9C6KDGcXB1FIpnQvL8RXIqtNaTTKfy5ZP3SXIe44rTkVKUUr9OTmQhhCi0OE3GmwEq17phy7xl1wFaNnd3o2vYVx9hiezShy4y17MFNg6G4Go2g9A43_rl9jObskXAgKSIbkBmfWALGBz2w4fIbsDisJ1M2U8IgaIbZL9w4_Dvm-SVhTbi-eN9lvy5_PZ79mMyv_5-NZvOJ7VKxTCREhqQmbaaV6lGrsGWBCjTlJe2yq0WokxzLJRKdakrq5sUBKYlgCYoeZZc7X0bDyuzDq6DsDUenHkI-LA0EKiHLZqcZxklsVxamYFSWkubq0rppqhqW9bk9WXvtR6rDpuaSqRuHZke__Tu1iz9xgguspTsyeHjo0PwdyPGwXQu1ti20KMfo0lLTjPROc-J-v4_6sqPoade7Vi5KrimmR9YS6AKXG89Ja53pmZaZASRF5pYF8-wCA12rvY9WkfxI4HaC-rgYwxoD0UKbnb7Z57dP9K9e9qhg-rftsl7HozY8Q</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Jîtcă, Carmen-Maria</creator><creator>Jîtcă, George</creator><creator>Ősz, Bianca-Eugenia</creator><creator>Pușcaș, Amalia</creator><creator>Imre, Silvia</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8187-126X</orcidid></search><sort><creationdate>20230401</creationdate><title>Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review</title><author>Jîtcă, Carmen-Maria ; Jîtcă, George ; Ősz, Bianca-Eugenia ; Pușcaș, Amalia ; Imre, Silvia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age</topic><topic>Cardiology</topic><topic>Dosage and administration</topic><topic>dosage form</topic><topic>Drug dosages</topic><topic>Drug stability</topic><topic>Evaluation</topic><topic>FDA approval</topic><topic>Federal regulation</topic><topic>Good Manufacturing Practice</topic><topic>oral liquid</topic><topic>Oral medication</topic><topic>pediatric</topic><topic>Pediatric cardiology</topic><topic>Pediatrics</topic><topic>Pharmaceutical industry</topic><topic>Review</topic><topic>Safety and security measures</topic><topic>stability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jîtcă, Carmen-Maria</creatorcontrib><creatorcontrib>Jîtcă, George</creatorcontrib><creatorcontrib>Ősz, Bianca-Eugenia</creatorcontrib><creatorcontrib>Pușcaș, Amalia</creatorcontrib><creatorcontrib>Imre, Silvia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jîtcă, Carmen-Maria</au><au>Jîtcă, George</au><au>Ősz, Bianca-Eugenia</au><au>Pușcaș, Amalia</au><au>Imre, Silvia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review</atitle><jtitle>Pharmaceutics</jtitle><addtitle>Pharmaceutics</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>1306</spage><pages>1306-</pages><issn>1999-4923</issn><eissn>1999-4923</eissn><abstract>The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibility and acceptability, the compounding practices are not endorsed by the health authorities, and achieving stability can be problematic. The purpose of this study is to provide a comprehensive overview of the stability of liquid oral dosage forms used in pediatric cardiology. An extensive review of the literature has been performed, with a particular focus on cardiovascular pharmacotherapy, by consulting the current studies indexed in PubMed, ScienceDirect, PLoS One, and Google Scholar databases. Regulations and guidelines have been considered against the studies found in the literature. Overall, the stability study is well-designed, and the critical quality attributes (CQAs) have been selected for testing. Several approaches have been identified as innovative in order to optimize stability, but opportunities to improve have been also identified, such as in-use studies and achieving dose standardization. Consequently, the information gathering and the results of the studies can be translated into clinical practice in order to achieve the desired stability of liquid oral dosage forms.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37111791</pmid><doi>10.3390/pharmaceutics15041306</doi><orcidid>https://orcid.org/0000-0001-8187-126X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1999-4923 |
ispartof | Pharmaceutics, 2023-04, Vol.15 (4), p.1306 |
issn | 1999-4923 1999-4923 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_6044b29f03f34a55993f65b59d7bcf8c |
source | Publicly Available Content Database; PubMed Central |
subjects | Age Cardiology Dosage and administration dosage form Drug dosages Drug stability Evaluation FDA approval Federal regulation Good Manufacturing Practice oral liquid Oral medication pediatric Pediatric cardiology Pediatrics Pharmaceutical industry Review Safety and security measures stability |
title | Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A27%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stability%20of%20Oral%20Liquid%20Dosage%20Forms%20in%20Pediatric%20Cardiology:%20A%20Prerequisite%20for%20Patient's%20Safety-A%20Narrative%20Review&rft.jtitle=Pharmaceutics&rft.au=J%C3%AEtc%C4%83,%20Carmen-Maria&rft.date=2023-04-01&rft.volume=15&rft.issue=4&rft.spage=1306&rft.pages=1306-&rft.issn=1999-4923&rft.eissn=1999-4923&rft_id=info:doi/10.3390/pharmaceutics15041306&rft_dat=%3Cgale_doaj_%3EA747471679%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2806570941&rft_id=info:pmid/37111791&rft_galeid=A747471679&rfr_iscdi=true |